Dr. Dumitrescu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1220 Rossmoor Pkwy
Walnut Creek, CA 94595Phone+1 925-947-3312Fax+1 925-947-3396
Education & Training
- Berkshire Medical CenterResidency, Internal Medicine, 2012 - 2015
- Carol Davila University of Medicine and PharmacyClass of 1992
Certifications & Licensure
- CA State Medical License 2014 - 2026
- MA State Medical License 2012 - 2015
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 94 citationsPhase I Study of the Novel Enhancer of Zeste Homolog 2 (EZH2) Inhibitor GSK2816126 in Patients with Advanced Hematologic and Solid Tumors.Timothy A. Yap, Jane N. Winter, Lisa Giulino-Roth, Jemma Longley, Juanita Lopez
Clinical Cancer Research. 2019-08-30 - 29 citationsSafety, efficacy, and dose response of the maturation inhibitor GSK3532795 (formerly known as BMS-955176) plus tenofovir/emtricitabine once daily in treatment-naive HI...Javier Morales-Ramirez, Johannes R. Bogner, Jean-Michel Molina, Johan Lombaard, Ira B. Dicker
Plos One. 2018-10-23 - 64 citationsSrc Family Kinase Activity Is Required for Murine Embryonic Stem Cell Growth and DifferentiationMalcolm A. Meyn, Steven J. Schreiner, Teodora Pene Dumitrescu, Gerard J. Nau, Thomas E. Smithgall
Molecular Pharmacology. 2005-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: